Medical Market Report

Global Transdermal Skin Patches Market By Type (Drug in Adhesive, Matrix, Reservoir, Vapor, Other), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135681
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global Transdermal Skin Patches Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global transdermal skin patches Market is segmented on the basis of Type, Application, and geography.
    The Global Transdermal Skin Patches Market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Transdermal Skin Patches Market Scope:

    By type, the market is segmented into Drug in Adhesive, Matrix, Reservoir, Vapor, and Other. By Application, the market is divided into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International, and Purdue Pharma.

    Key Market Segments

    Type

    Drug in Adhesive

    Matrix

    Reservoir

    Vapor

    Other

    Application

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    Key Market Players included in the report:

    Johnson & Johnson

    Novartis AG

    Mylan N.V.

    Teva Pharmaceutical Industries

    Luye Pharma Group

    Hisamitsu Pharmaceutical

    Mundipharma International

    Purdue Pharma

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Transdermal Skin Patches Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Transdermal Skin Patches Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global Transdermal Skin Patches Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Transdermal Skin Patches Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global Transdermal Skin Patches Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global Transdermal Skin Patches Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global Transdermal Skin Patches Market sub-markets, depending on key regions (various vital states).
    To analyze Global Transdermal Skin Patches Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global Transdermal Skin Patches Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global Transdermal Skin Patches Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global Transdermal Skin Patches Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Transdermal Skin Patches Market Overview
    

    3.1. Global Transdermal Skin Patches Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Manufacturer Intensity Map4. Global Transdermal Skin Patches Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Transdermal Skin Patches Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Drug in Adhesive
    

      4.4. Matrix
    

      4.5. Reservoir
    

      4.6. Vapor
    

      4.7. Other5. Global Transdermal Skin Patches Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Transdermal Skin Patches Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospital Pharmacies
    

      5.4. Retail Pharmacies
    

      5.5. Online Pharmacies6. Global Transdermal Skin Patches Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Global Transdermal Skin Patches Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Global Transdermal Skin Patches Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Global Transdermal Skin Patches Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia
    

      6.4. Latin America
    

        6.4.1. Latin America Global Transdermal Skin Patches Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Global Transdermal Skin Patches Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Transdermal Skin Patches Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Johnson & Johnson
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3. 3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Novartis AG
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4. 4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Mylan N.V.
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5. 5. Key Strategies and Developments  7.6. Teva Pharmaceutical Industries
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Luye Pharma Group
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Hisamitsu Pharmaceutical
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Mundipharma International
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7. 10.Purdue Pharma
    

        7. 10.1. Company Overview
    
    7. 10.2. Financial Highlights
    
    7. 10.3. Product Portfolio
    
    7. 10.4. SWOT Analysis
    
    7. 10.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10.Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.